
| Reference Listed Drug | NDA Holder | Generic Drug Name | ANDA Applicant(s) | Indication | Launch Date |
| Avapro | Sanofi Aventis | Irbesartan | Teva | High blood pressure treatment | Apr. 2, 2012 |
| Avalide | Sanofi Aventis | Irbesartan-hydrochlorothiazide | Teva | High blood pressure treatment | Apr. 2, 2012 |
| Sular Extended Release | Shionogi | Nisoldipine extended release tablets | Prasco | Treatment of high blood pressure | Apr. 2, 2012 |
| Mesnex Injection | Baxter Healthcare | Mesna injection | Mylan | Prophylactic agent in reducing the incidence of ifosfamide-induced hemorrhagic cystitis | Apr. 3, 2012 |
| Provigil | Cephalon/Teva | Modafinil tablets | Par Pharmaceutical | Wakefulness-promoting agent | Apr. 6, 2012 |
| Vancocin HCl Capsules | ViroPharma | Vancomycin hydrochloride | Watson Pharmaceuticals | Treatment of C. difficile-associated diarrhea and enterocolitis | Apr. 10, 2012 |
| Vancocin HCl Capsules | ViroPharma | Vancomycin hydrochloride | Akorn | Treatment of C. difficile-associated diarrhea and enterocolitis | Apr. 10, 2012 |
| Vancocin HCl Capsules | ViroPharma | Vancomycin hydrochloride | Prasco | Treatment of C. difficile-associated diarrhea and enterocolitis | Apr. 11, 2012 |
| Mucinex | Adams Respiratory Therapeutics | Guaifenesin extended-release tablets | Perrigo | Relieve chest congestion and make coughs more productive | Apr. 12, 2012 |
| Lescol Capsules | Novartis | Fluvastatin capsules | Mylan | Familial and nonfamilial hypercholesterolemia and mixed dyslipidemia | Apr. 13, 2012 |
| Fortamet | Shionogi | Metformin hydrochloride extended-release tablets | Watson Pharmaceuticals | Adjunct to diet and exercise to lower blood glucose | Apr. 19, 2012 |
| Zyprexa Tablets | Eli Lilly and Company | Olanzapine | Mylan | Treatment of schizophrenia and acute treatment of manic or mixed episodes associated with bipolar 1 disorder and maintenance treatment of bipolar 1 disorder | Apr. 24, 2012 |
| Stalevo | Orion Corporation/Novartis | Levodopa, carbidopa and entacapone | Wockhardt | Treatment of Parkinson's disease | Apr. 24, 2012 |
| Doryx | Mayne Pharmaceutical | Dolycycline hyclate delayed-release tablets | Mylan | Antimicrobial | Apr. 30, 2012 |
| Plavix | Sanofi Aventis | Clopidogrel tablets | Mylan | Acute coronary syndrome and recent myocardial infarction, stroke or established peripheral arterial disease | May. 17, 2012 |
| Prevacide 24HR Capsules | Novartis | Lansoprazole | Perrigo | Treatment of frequent heartburn | May. 18, 2012 |
| Requip XL | GlaxoSmithKline | Ropinirole extended-release tablets. | Actavis | Treatment for Parkinson's disease | May. 18, 2012 |
| Viramune Tablets | Boehringer Ingelheim | Nevirapine tablets. | Mylan | Combination antiretroviral treatment of HIV-1 infection | May. 23, 2012 |
| Lipitor | Pfizer | Atorvastatin calcium tablets | Mylan | Treatment of hypercholesterolemia and mixed dyslipidemia | May. 29, 2012 |
| Adalat CC | Bayer | Nifedipine extended-release tablets | Actavis | Treatment of hypertension | May. 30, 2013 |
| Requip XL | GlaxoSmithKline | Ropinirole hydrochloride XR | Dr. Reddy's Laboratories | Treatment for Parkinson's disease | Jun. 7 2012 |
| Exelon | Novartis | Rivastigmine tartrate Capsules | Breckenridge Pharmaceutical | Treatment of mild to moderate dementia of the Alzheimer's type, and for the treatment of mild to moderate dementia associated with Parkinson's disease | Jun. 14 2012 |
| Exelon | Novartis | Rivastigmine tartrate capsules | Alembic Pharmaceuticals | Treatment of mild to moderate dementia of the Alzheimer's type, and for the treatment of mild to moderate dementia associated with Parkinson's disease | Jun. 14 2012 |
| Symbyax | Lilly USA | Olanzapine/fluoxetine | Teva | Treatment-resistant depression and bipolar I depression | Jun. 21, 2012 |
| Duac Gel | Stiefel Laboratories | Clindamycin phosphate and benzoyl peroxide 1.2%/5% topical gel | Perrigo | Topical treatment of inflammatory acne vulgaris | Jun. 27 2012 |
| Thiamine Hydrochloride | Thiamine hydrochloride | Mylan | Thiamine deficiency | Jun. 28 2012 | |
| Boniva | Roche | Ibandronate | Dr. Reddy's Laboratories | Treatment of osteoporosis in women after menopause | Jun. 29 2012 |